EPH2 Adverse Outcomes Associated with Concurrent Gabapentin, Opioid, and Benzodiazepine Utilization: A Nested Case-Control Study
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.755
https://www.valueinhealthjournal.com/article/S1098-3015(22)00956-1/fulltext
Title :
EPH2 Adverse Outcomes Associated with Concurrent Gabapentin, Opioid, and Benzodiazepine Utilization: A Nested Case-Control Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00956-1&doi=10.1016/j.jval.2022.04.755
First page :
Section Title :
Open access? :
No
Section Order :
10679